Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Lutropin, alpha subunit (substance) |
Is a |
False |
Lutropin alfa |
Inferred relationship |
Some |
|
Recombinant human luteinizing hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lutropin alfa |
Inferred relationship |
Some |
|
Recombinant human follicle stimulating hormone alfa 150iu/lutropin alfa 75iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lutropin alfa |
Inferred relationship |
Some |
|
Product containing follitropin alfa and lutropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lutropin alfa |
Inferred relationship |
Some |
2 |
Lutropin alfa 75iu injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lutropin alfa |
Inferred relationship |
Some |
|
Product containing lutropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lutropin alfa |
Inferred relationship |
Some |
1 |
Lutropin alfa only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lutropin alfa |
Inferred relationship |
Some |
1 |
Product containing only follitropin alfa and lutropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lutropin alfa |
Inferred relationship |
Some |
2 |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lutropin alfa |
Inferred relationship |
Some |
1 |
Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lutropin alfa |
Inferred relationship |
Some |
1 |
Lutropin alfa only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lutropin alfa |
Inferred relationship |
Some |
1 |
Lutropin alfa-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lutropin alfa |
Inferred relationship |
Some |
1 |